Xin Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xin Zhao has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Guangcheng Wei
Sports Medicine Department, Wangjing Hospital, China Academy of China Medical Sciences, Chaoyang District, Beijing, China
1 shared publication Jiming Yu
The Second Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou, People’s Republic of China
1 shared publication- Jinjie Shi
Graduate School, Beijing University of Chinese Medicine, Beijing, People’s Republic of China
1 shared publication - Ke Zhu
Rheumatology Department, Wangjing Hospital of China Academy of Chinese Medical Sciences, Beijing, People’s Republic of China
1 shared publication - Shen Wang
Orthopedics Department, Nanjing Integrated Traditional Chinese and Western Medicine Hospital, Nanjing, People’s Republic of China
1 shared publication - Wei Cao
Department of Rheumatology, Wang Jing Hospital of China Academy of Chinese Medical Sciences, Beijing 100102, China
1 shared publication
Latest Publications
- Open Access
- 1 December 2024
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 17, 11845-11860
New Posttranslational Modification Lactylation Brings New Inspiration for the Treatment of Rheumatoid Arthritis
Lactic acid (LA) is an essential glycolytic metabolite and energy source in the body, which is present in high levels in the synovial fluid of patients with rheumatoid arthritis (RA) and is a reliable indicator for identifying inflammatory arthritis. LA not only acts as an inflammatory amplifier in RA, recent studies have found that novel posttranslational modification (PTM) lactylation mediated by LA may also play a key role in RA. Single-cell sequencing showed that the RA lactylation score of patients with RA was significantly increased, and core lactylation-promoting genes, including NDUFB3, NGLY1, and other genes, were found to be potential biomarkers of RA. More studies have shown that lactylation can regulate genes in various cells, such as fibroblast-like synoviocytes (FLSs) and macrophages, thus playing a special role in the development and occurrence of autoimmune diseases, neurological diseases, and cancer diseases. In this paper, we review the research on lactylation in RA-related cells and mechanisms and bring new insights into the pathogenesis, diagnosis, and treatment of RA.
- 1 December 2024
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 17, 11845-11860
Open AccessNew Posttranslational Modification Lactylation Brings New Inspiration for the Treatment of Rheumatoid Arthritis
Lactic acid (LA) is an essential glycolytic metabolite and energy source in the body, which is present in high levels in the synovial fluid of patients with rheumatoid arthritis (RA) and is a reliable indicator for identifying inflammatory arthritis. LA not only acts as an inflammatory amplifier in RA, recent studies have found that novel posttranslational modification (PTM) lactylation mediated by LA may also play a key role in RA. Single-cell sequencing showed that the RA lactylation score of patients with RA was significantly increased, and core lactylation-promoting genes, including NDUFB3, NGLY1, and other genes, were found to be potential biomarkers of RA. More studies have shown that lactylation can regulate genes in various cells, such as fibroblast-like synoviocytes (FLSs) and macrophages, thus playing a special role in the development and occurrence of autoimmune diseases, neurological diseases, and cancer diseases. In this paper, we review the research on lactylation in RA-related cells and mechanisms and bring new insights into the pathogenesis, diagnosis, and treatment of RA.